Palantir has seen extreme volatility despite strong revenue growth, but its high valuation could be a concern.

In this week’s edition of InnovationRx, we look at Trump's massive health agency layoffs, Palantir’s trade secret lawsuit, ...

Morgan Stanley analysts noted last week that Palantir was at higher risk for downward estimate revisions than other stocks in ...

Palantir (PLTR) shares fell 3% in premarket trading Wednesday as fears over U.S. defense budget cuts collided with rising geopolitical tension.

Based on estimates from PwC, AI can boost global gross domestic product by 26% come the turn of the decade. This is north of ...

Palantir achieved $1.25B FCF in FY24 with 29% revenue growth. U.S. commercial revenue soared 54%, fueled by scalable AI. See ...